Clinical Trial Update: Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov notes a Phase 1/2 study evaluating OXY111A in hepatopancreato-biliary cancers, including pancreatic neoplasms and hepatocellular carcinoma, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Neoplasms
• Hepatocellular Carcinoma
• Pancreatic Neoplasms

Drugs mentioned

• OXY111A

Snippet

Sponsor: University of Zurich | Conditions: Pancreatic Neoplasms, Hepatocellular Cancer | Phase 1, Phase 2 | Status: UNKNOWN